Research ArticleArticle
Molecular Interactions and Implications of Aldose Reductase Inhibition by PGA1 and Clinically Used Prostaglandins
Beatriz Díez-Dacal, Francisco J. Sánchez-Gómez, Pedro A. Sánchez-Murcia, Ivana Milackova, Tahl Zimmerman, Jana Ballekova, Elena García-Martín, José A. G. Agúndez, Severine Gharbi, Federico Gago, Milan Stefek and Dolores Pérez-Sala
Molecular Pharmacology January 2016, 89 (1) 42-52; DOI: https://doi.org/10.1124/mol.115.100693
Beatriz Díez-Dacal
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Francisco J. Sánchez-Gómez
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Pedro A. Sánchez-Murcia
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Ivana Milackova
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Tahl Zimmerman
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Jana Ballekova
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Elena García-Martín
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
José A. G. Agúndez
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Severine Gharbi
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Federico Gago
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Milan Stefek
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
Dolores Pérez-Sala
Chemical and Physical Biology Department, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas, Madrid, Spain (B.D.-D., F.J.S.-G., T.Z., D.P.-S.); Department of Biomedical Sciences, Universidad de Alcalá, Madrid, Spain (P.A.S.-M., F.G.); Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia (I.M., J.B., M.S.); Department of Pharmacology, University of Extremadura, Cáceres, Spain (E.G.-M., J.A.G.A.); Centro Nacional de Biotecnología, Madrid, Spain (S.G.)
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Prostaglandins Inhibit Aldose Reductase
Beatriz Díez-Dacal, Francisco J. Sánchez-Gómez, Pedro A. Sánchez-Murcia, Ivana Milackova, Tahl Zimmerman, Jana Ballekova, Elena García-Martín, José A. G. Agúndez, Severine Gharbi, Federico Gago, Milan Stefek and Dolores Pérez-Sala
Molecular Pharmacology January 1, 2016, 89 (1) 42-52; DOI: https://doi.org/10.1124/mol.115.100693
Research ArticleArticle
Prostaglandins Inhibit Aldose Reductase
Beatriz Díez-Dacal, Francisco J. Sánchez-Gómez, Pedro A. Sánchez-Murcia, Ivana Milackova, Tahl Zimmerman, Jana Ballekova, Elena García-Martín, José A. G. Agúndez, Severine Gharbi, Federico Gago, Milan Stefek and Dolores Pérez-Sala
Molecular Pharmacology January 1, 2016, 89 (1) 42-52; DOI: https://doi.org/10.1124/mol.115.100693
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement